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Summary.-Experiments were undertaken to test a new hypothesis for the mech-
anism underlying the Revesz effect. The hypothesis proposes that lethally irradia-
ted (LI) tumour cells enhance the take probability of a small number of transplanted
viable (V) tumour cells mixed with them by exerting a thromboplastic effect at the
site of injection; local fibrin formation prevents emigration of V cells from the site
or secures their survival there. The evidence presented to support this hypothesis
is as follows: in the case of 3 isogeneically transplanted tumours, admixed particu-
late brain extract simulated the effect of LI cells in increasing the take probability
of V cells; brain extract simulated the effect of LI cells in greatly delaying the dis-
appearance of 125IUdR-labelled viable carcinoma cells from the injection site; V cells
acquired a raised take probability by their incorporation in fibrin clots; it was con-
firmed that admixed erythrocytes increased the take probability of V cells; using a
newly devised microscopical test for detection of the thromboplastic activity of
individual cells, it was found that cell death was almost always required for the
display of such activity; lymphocytes and bone marrow cells, ineffective in enhancing
the take of V cells, were almost totally devoid of thromboplastic activity. Possible
explanations are given for failure of a fibrinogen depleting agent, ancrod (Arvin) to
inhibit the Revesz effect when administered to recipients. It is concluded that the
evidence strongly supports the hypothesis presented whilst seriously weakening the
long-standing theories that admixed LI cells act by provision of nutrients or by
local quenching of postulated immune reactivity.
RE'vtsz (1956) first described the
stimulation of the growth of transplanted
murine tumours which results when a
preponderance of lethally irradiated (LI)
tumour cells are added to an inoculum of
viable (V) cells. It is remarkable that
further studies of this effect by Revesz
and by others during the subsequent
17 years have not led to an understanding
of the mechanism of the effect.
In a recent report from this laboratory
(Hewitt, BlakeandPorter, 1973) theresults
offully quantitativetransplantation assays
were described using acarcinoma ("N.T.")
of spontaneous origin in a CBA/Ht mouse;
the TD50 (number of viable cells required
for successful transplantation to 50%
of injected sites) was 7000 for viable cells
21
injected alone and only 4 for viable cells
injected in mixture with 105 LI cells.
(In the experiments reported here these
values have changed to about 2100 and
11 respectively.) Under both conditions
of transplantation, the relationship be-
tween the number of viable cells per
inoculum and proportion of takes con-
formed to a Poisson distribution for
single unit transplantation. From this
and other evidence it was concluded that
admixed LI cells acted by increasing the
proportion of viable cells which contri-
buted to tumour initiation, rather than
by influencing the growth characteristics
of the viable cells. Other findings of
interest in the present context were as
follows: unirradiated normal lymphocytes2L. J. PETERS AND H. B. HEWITT
and LI normal marrow cells did not
influence the TD50 for viable cells when
injected in mixture with them; LI cells
of other tumours, either of the same or
of a foreign mouse strain, varied widely
in their ability to reduce the TD50
when added to the inocula; LI cells of
one allogeneic tumour (of the WHT/
Ht mouse strain) reduced the TD50 to
25 cells; and LI cells of " N.T." itself
were far more effective in reducing the
TD50 than the use of whole-body irradia-
ted mice for the assay of viable cells.
Overall consideration of the above
findings, with special reference to the
striking heterogeneity of the types of LI
cell able to exert the effect, encouraged us
to doubt the two most commonly asserted
hypotheses for the mechanism of the
Revesz effect: that LI cells abrogate or
saturate a low level of host immunity
against the tumour cells and facilitate
their survival and growth; or that the LI
cells, or the products of their disintegra-
tion, restore a relative nutritional defici-
ency assumed to be suffered by the viable
cellsaftertheirimplantationintothetissues.
It has long been known that a variety
of factors influence the ability of circula-
ting tumour cells to implant and give rise
to " metastatic " growth, whether the
cells are injected intravenously or have
been disseminated naturally from a pri-
mary implanted tumour (Wood, Holyoke
and Yardley, 1961). Prominent among
such factors have been blood coagul-
ability, many investigators having found
that anticoagulants reduce the tendency
of disseminated cells to " seed " in the
tissues. It occurred to us to explore
possible analogies between the factors
governing metastasis and those governing
the ability of injected viable tumour
cells to give rise to progressive tumours.
The question arose whether LI cells
enhance the conditions for growth of
viable tumour cells injected subcutaneous-
ly by exerting a local thromboplastic
influence. This paper reports a series
of experiments by which an attempt was
made to answer this question.
MATERIALS AND METHODS
Mice and tumours.-Mice of 2 inbred
strains were used: CBA/Ht and WHT/Ht.
The tumours used were: CBA Carcinoma
" N.T.", CBA Sarcoma "' F ", CBA Leu-
kaemia IV, WHT AscitesTumourIandWHT
Squamous Carcinoma " G ". All these tu-
mours arose spontaneously and have been
maintained by serial transplantation in the
mouse substrain of origin. References to
their use in previous experiments have been
given by Hewitt et at. (1973).
Transplantation assays of tumour cells.-
The methods for preparing single-cell sus-
pensions from solid tumours have been
described previously (Hewitt, 1966). The
values of TD50 and their confidence limits
were calculated from the data of assays by
statistical methods described recently (Porter,
Hewitt and Blake, 1973).
Figure 1 shows, for CBA Carcinoma
" N.T.", the dependence of percentage tu-
mour incidence on the log number of viable
cells injected per site. The right hand curve
is for viable cells injected alone, and the
left hand curve is for viable cells injected in
mixture with 3.5 x 104 LI cells per inoculum.
Comparison of these two curves shows that
an inoculum of 200-300 viable cells (2.3-
2-5 log) gives a take incidence of under 10%
without LI cells, and an incidence approach-
ing 100% with LI cells. The finding pro-
vides the basis ofa number ofour experiments
using this tumour, in which the enhancing
effect of an additive has been demonstrated
by its ability to give a relatively high inci-
dence of tumours from 200 to 300 viable
cells.
Preparation of LI tumour cells.-Cell
suspensions prepared as for viable cells were
exposed to 7-8 krad while enclosed in a
glass vial standing in an ice bath. All LI
suspensions were tested for inactivation by
injection into appropriate mice which were
observed for at least 5 months; no suspen-
sions so tested have given rise to tumours.
Preparation of brain extract.-Several
brains were excised from normal mice and
homogenized by grinding with sand. Phos-
phate buffered saline was added to give a
final brain tissue concentration of 250 mg/ml.
The diluted homogenate was lightly centri-
fuged to remove connective tissue fragments
and sand and the opaque supernatant fluid
was used in the experiments. In one experi-
ment the supernatant was further centri-
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fuged (2100 g for 10 min) to provide an
opalescent particle-free supernatant fluid.
Preparation of clots as vehicles for tumour
cell transplantation.-Two techniques were
used: Preformed fibrin clots were made by
suspending viable tumour cells to the re-
quired density in a 10% solution of pure
human fibrinogen (Koch-Light Laboratories)
in saline; aliquots of 0-1 ml were clotted
with thrombin in vitro and the discrete clots
were implanted subcutaneously through a
small incision. In situ clots were produced
as follows: fresh mouse blood was collected
into one-tenth its volume of 3X13% sodium
citrate containing 10% E-amino caproic
acid; platelet-poor plasma was separated by
centrifugation and viable tumour cells were
added to the required density; aliquots of
0-5 ml of the mixed suspension (to provide
four 0-1 ml inocula per mouse) were recalci-
fied immediately before injection; the 4
injections were completedwithinthe40-60 sec
clotting time so that the inocula clotted
in vivo almost immediately after injection;
this was verified by the formation of pal-
pable nodules at the injection sites.
Experiments u?sing cells labelled with
5-125iodo-21-deoxyuridine (125IUdR).-The
thymidine analogue 125IUdR is incorporated
into the DNA of proliferating cells and is
released only after cell death (Commerford,
1965). Itisverylittle re-utilized (Dethlefson,
1971) and therefore provides a suitable
label for studying the fate ofinjected tumour
cells.
The method used for in vitro labelling of
CBA " N.T." cells, based on that of Fidler
(1970), was as follows: a tumour cell suspen-
sion was prepared as described above and
approximately 4 x 105 viable cells were
plated into each of twelve 5 cm plastic petri
dishes with 4 ml of Eagle's MEM containing
15% foetal calf serum and '25JUdR 0-4 ,uCi/
ml (specific activity 1-6 mCi/mg). The cul-
tures were incubated at 37°C in an atmos-
phere of air containing 5% C02. In some
experiments, the '25IUdR was not added
until the cells had been in culture overnight;
in all cases, however, the cultures were
harvested after an exposure of 24 hours to
the labelled DNA precursor. After pouring
off the medium, the cells were removed with
phosphate buffered saline containing trypsin
0-2%, pancreatin 0-05%, and sodium citrate
0-3%; they were then washed repeatedly in
phosphate buffered saline at pH 7-3 until
the activity of the supernate per 0-1 ml was
indistinguishable from background. The cells
were finally re-suspended in Tyrode solution
containing 5% mouse serum and were sedi-
mented under gravity in narrow glass tubes
to remove clumps. Counts of " viable "
and "dead" cells were made on phase-
contrast appearances. No evidence ofradio-
toxicity was observed with this technique,
as measured by in vivo assays of cultured,
labelled cells.
Labelling indices were determined by
fixing a sample of the cells in methanol/
glacial acetic acid (3 : 1) and exposing smears
ofthese fixed cells to Ilford K5 nuclear liquid
emulsion for 6 days. After developing, the
autoradiographs were counterstained with
aceto-orcein. The percentage of labelled
cells so determined was at least 90% in
these experiments.
All measurements of radioactivity were
made with a LKB Wallac 80,000 automatic
gamma sample counter; 5000 counts were
accumulated for each sample. The level of
activity attained was approximately 1 ct/sec/
100 cells.
Recognition of thromboplastic effect of
individual cells.-The following test was
devised to permit comparison of thrombo-
plastic activity between cells of different
origins and morphology as seen by phase-
contrast microscopy.
Pooled samples of human blood contain-
ing sodium EDTA as anticoagulant were
centrifuged and the plasma was recovered.
To 2 ml of EDTA treated plasma was added
5 i.u. of heparin followed by 2 mg CaCl2,
each in 0-1 ml of physiological saline. Sus-
pensions of tumour or normal cells to be
examined were well washed in Tyrode solu-
tion and diluted to contain approximately
3000 cells/mm3. Equal volumes of cell sus-
pension and prepared human plasma were
mixed and the mixture was used to fill a
Turck haemacytometer. The filled haema-
cytometer was incubated at 37°C for 20 min
in a humidified chamber before examination
by phase-contrast microscopy. A propor-
tion of the cells in many such preparations
display a very striking appearance, being
surrounded by a corona of needle-like fibres
extending radially from the cell margin;
the length of the fibres extends gradually
until they are several cell diameters in
length. Further incubation is associated
with increasing density of the fibres roundL. J. PETERS AND H. B. HEWITT
affected cells, while initially unaffected cells
usually remain quite free from fibres. Thus,
differences between affected and unaffected
cells appear to represent qualitative, rather
than quantitative, differences of cellular
thromboplastic capacity. Strong evidence
that the fibres are of fibrin is provided by
our observation that fibres do not form in
serum, that they can be seen to disappear
when trypsin is allowed to diffuse into the
chamber, and that they form in great density
around deposits of dried brain extract and
around megakaryocytes. It is concluded
that formation of the fibres is associated with
coagulative factors accessible at the cell
surface or secreted by the cells. For con-
venience, affected cells are referred to as
C9 star" cells. The proportion of " star"
cells in a suspension is determined by count-
ing in relation to the density of living and
dead cells present in the suspension.
Treatment of mice with ancrod (Arvin).
Arvin (Twyford Laboratories Ltd) is a
purified enzyme fraction of Malayan pit
viper venom. Injected into mammals, this
has a thrombin-like action: fibrinogen is con-
verted to fibrin which is removed by fibrinoly-
sis, leaving the blood in a temporarily inco-
agulable condition from severe hypofibrino-
genaemia. In the experiments reported by
Hagmar (1972), repeated intraperitoneal
injections of the drug into mice were com-
plicated and restricted by the occurrence of
intraperitoneal haemorrhage, presumably
from damage to blood vessels by the injecting
needle. We have completely avoided this
complication by giving the injections in the
mid-line through the avascular linea alba.
Our schedule of treatment of CBA mice,
based on Hagmar's detailed observations,
was as follows: 3 doses of 50 u/kg body
weight at 4-hour intervals, followed after
8 hours by 8-hourly injections of 100 u/kg;
treatment was maintained for 4 days. Sam-
ples of tail vein blood taken from treated
mice immediately before the administration
of scheduled doses were taken into capillary
tubes and incubated at 37°C; coagulation
of blood was sought at intervals up to
16 hours by inspection of a capillary, and
of its contents after their expulsion; no
evidence of coagulation was seen in any
specimen taken during the course of treat-
ment. In view of Hagmar's (1972) detailed
examination of the effect of ancrod on
thrombin clotting time and fibrinogen con-
centration. we have not repeated these
quantitative assessments of impaired blood
coagulability. In the experiments to be
reported, tumour cells were injected sub-
cutaneously into ancrod-treated mice soon
after injection of the third dose of 50 u/kg.
EXPERIMENTS AND RESULTS
1. Effect of admixed brain extract on the
take ofviable tumour cells
Fully quantitated transplantation
assays have been done with tumours
CBA Carc. " N.T." and CBA Sarc. " F ",
in which the effect of admixed brain
extract, a rich source of thromboplastin,
was compared with that of admixed LI
cells of the corresponding tumours. The
results of these assays are shown in Table
I. The control assays for each inter-
comparison have been pooled. It is
clear that the reduction of TD50 obtained
with LI cells is closely approximated by
brain extract.
In addition, single point assays of
CBA " N.T." have been done to compare
the efficacy of different preparations of
brain extract: BE (1) standard extract
prepared as described previously in this
paper; BE (2) as above, except that no
sand was used in grinding the brains;
minimal sedimentation was used to re-
move any larger fragments of connective
tissue but essentially this was a " whole "
brain extract. BE (3) the standard
extract was centrifuged at 2100 g for
10 min to remove virtually all particulate
material, leaving a " soluble " extract.
By using 200 V cells in these assays,
excellent discrimination was obtained
between effective and non-effective prep-
arations (see Fig. 1). Results (tumour
takes/sites injected) were as follows:
BE (1), 23/24; BE (2), 24/24; BE (3),
1/28; controls (no brain extract), 4/28.
Thus, it is clear that the " soluble"
extract is ineffective, whereas there is no
difference between the standard and
" whole " preparations. This difference,
we believe, is due to the requirement of a
sustained thromboplastic influence at the
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TABLE I.-TD50 Values for Viable Cells of Two Tumours Injected Alone, with LI Cells,
or with Brain Extract (BE)
TD50 (95% confidence limits)
Ttumour V only V + LI V + BE
CBACarc. "N.T." 2080 11-1 28-2
(1466-2951) (6 6-18-4) (17-1-46-6)
CBASarc. " F " 611 7-6 8-9
(431-867) (4* 6-12 * 7) (5 *4-14*8)
injection site; the particulate extracts
fulfil this requirement while the soluble
extract does not.
That the effect of brain extract is not
peculiar either to the two tumours used,
or to the CBA strain, was demonstrated
by transplanting with or without brain
extract 100 V cells of the WHT Sq. Ca.
" G ". The tumour take incidences were,
respectively, 22/24 and 4/24.
2. Fate of 1251UdR-labelled tumour cells
injected subcutaneously
In these experiments it was necessary
to use more than our usual 200-300 V
cells in order to obtain measurable levels
of activity per inoculum without radio-
toxicity. The two experiments described
here involved inocula of 800-1000 V cells,
which, by reference to Fig. 1, still permit
good discrimination between assays of V
cells alone or with excess LI cells.
In the first experiment approximately
800 V cells of CBA " N.T." labelled with
125IUdR were injected subcutaneously,
with or without 4 x 105 LI cells, into the
hind legs of mice. At intervals following
injection, groups of mice were killed with
ether, their legs were amputated and the
residual activity at the injection sites
was counted. Results are shown in
Table II. It will be seen that by 5 days
after injection, the residual activity was
more than 30 times greater with added
LI cells than without a highly significant
difference. It is reasonable to assume
VIABLE CELLS INJECTED(4DO)
FIG. 1. Relationship between number of viable cells of CBA Ca. " N.T." per inoculum and tumour
incidence. The open points are for viable cells injected alone (combined results of 2 assays) The
solid points are for viable cells mixed with 3 - 5 x 104 LI cells (results of one assay done in parallel
with one ofthe above assays).L. J. PETERS AND H. B. HEWITT
that the cells represented by this residual
activity are those injected cells which
actually contribute to tumour develop-
ment, and it is of interest to compare the
measured activity levels with the tumour
take incidences which resulted from the
same inocula as set out in Table III.
Conversion of residual activity measure-
ments to equivalent cells can be only
approximate because of the contribution
to initial activity of labelled non-viable
cells and ofnon-DNA-bound label. Results
of other experiments not reported here
suggest that the rapid decline in activity
over the first 12 hours after injection is
due partly to these elements. Nonethe-
less, it isreadily apparent that theeffective
" take unit " consists ofonly a very few V
cells, and that at 120 hours the relative
number of injected cells retained locally
is greatly augmented by their admixture
with LI cells; indeed, the " stimulation "
of tumour growth can be interpreted in
these terms.
In a similar experiment, the effect of
brain extract in place of LI cells was
observed. Figure 2 indicates graphically
the qualitative similarity of the data,
although with brain extract the final
ratio of activities was 1: 12 compared
with 1: 30 for LI cells. This is in
accord with the slightly smaller effect of
brain extract in reducing the TD50, as
described previously in this paper.
3. Evidence ofretardation ofcell emigration
by brain extract
When cells of CBA Leukaemia IV are
injected subcutaneously, the recipient
inevitably develops generalized leukaemia.
In most cases no lesion develops at the
injection site, though occasionally an
ill-defined flattened infiltration may be
noted.
If emigration of the leukaemia cells
were retarded, two effects should be
noted: local tumour growth and pro-
longed survival. In the present experi-
ment, 104 leukaemia cells were injected
with or without brain extract into groups
of 6-8 mice. After 17 days, when the
TABLE II.-Residual 1251 Activity at Intervals after the Injection of 800 125IUdR-labelled
V Cells with or without Admixed LI Cells
1251 activity (ct/sec±s.e. mean)*
Hours after , A
injection V only V + LI t test
13-01+1 -13
9-62+2-04 12-72±1-37









* 6 sites per group; measurements corrected for background.
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* See text.
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Fig. 2. Rate of loss of viable cells of CBA " N.T." from subcutaneous injection sites, as measured by
residual 125I activity following prior incorporation of 125IUdR into the DNA of the cells. Graph
(a) indicates the activity loss when 800 viable cells were injected alone (solid points) or mixed with
4 x 105 lethally irradiated cells (open points). Graph (b) shows the corresponding curves for
1000 viable cells injected alone (solid points) or mixed with brain extract (open points). Error
bars represent the s.e. mean of 6 sites for each data point.L. J. PETERS AND H. B. HEWITT
disease was well developed, the mice were
killed, the presence or absence of a
local tumour was noted and the spleens
were weighed. Results are shown in
Table IV. The increase of local tumour
incidence with brain extract is not statis-
tically significant, but the reduction in
spleen weights is highly significant
(P < 0.005). Brain extract injected re-
motely had no effect on evolution of the
disease.
TABLE IV.-Effect of Brain Extract (BE)
on Dlissemination of Leukaemia Cells
from Subcutaneous Sites of Injection
Mean weight of
Local tumour spleen (g)
Inoculum incidence s.e.




+ BE at remote site
5/8 0*681 +0*277
1/8 1*172±0 284
These results clearly suggest an inhibit-
ing effect of admixed brain extract on the
dissemination of leukaemia cells from the
site of injection. The alternative explan-
ation, that the brain extract was toxic
to the cells, is made untenable by our
observation that brain extract increased
the take probability from limited numbers
of viable cells of the three solid tumours
tested.
4. Transplantation of tumour cells infibrin
clots
The demonstration that brain extract
greatly reduced the number of At cells
required for transplantation in at least
3 different systems suggested that the
formation of a fibrin mesh at the injection
site might be an important factor in the
establishment of a successful graft.
In the first experimental design, we
observed the result of implanting 300 V
cells of CBA " N.T." in preformed fibrin
clots. Progressive tumours developed in
all recipients (6/6); the probability of this
occurring with 300 V cells injected alone
is less than 1: 1000 (see Fig. 1).
To exclude the possibility that surgical
trauma associated with surgical implanta-
tion influenced the take probability, we
assayed 210 V cells of CBA " N.T." in
in situ clots by the technique described in
the previous section. The resulting tu-
mour incidence was 20/20.
Thus, it is apparent that the number
of cells required for tumour take was
reduced dramatically by incorporation of
cells in clots by both techniques.
The mean latent period before appear-
ance of tumours from preformed fibrin
clots (40 days) was rather long (Hewitt
et al., 1973), possibly reflecting the in-
creased diffusion distances required for
provision of cell nutrients. Successful
tumour takes with relativelv small num-
bers of V cells under conditions which
increase the diffusion distances for nutri-
tional provision argue strongly against the
assertion that nutritional deficiences limit
the take of small numbers of cells injected
directly into the subcutaneous tissue
without additives.
5. Effect of added erythrocytes on tumour
take incidence
The finding of Yatvin, Stone and
Clifton (1973) that growth of the MTGB
carcinoma was promoted by the addition
of washed erythrocytes to the tumour
cell inoculum prompted us to test this
adjuvant in a transplantation assay using
CBA " N.T." Freshly collected citrated
mouse blood was centrifuged and the
packed cells were washed twice in ice-cold
saline. A 3300 suspension by volume
of these cells in Tyrode solution was then
used as a vehicle for assay of 280 V cells
of the CBA " N.T." The tumour take
incidence was 12/24, compared with 0/24
in a parallel assay of 280 V cells alone.
The results confirm the finding of
Yatvin et al. (1973), using a different
tumour and end point. It is relevant to
note here that erythrocyte lysate has
thromboplastic (Quick, Georgatsos and
Hussey, 1954) and antifibrinolytic (Blo-
field and Hawkey, 1967) properties.
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6. Thromboplastic activity of individual
cells
Using the microscopic technique des-
cribed in the previous section for recogni-
tion of thromboplastic activity by indi-
vidual cells (" star " cells), we have
examined cell preparations from 4 differ-
ent normal tissues and 16different tumours
of the mouse. The results of these
examinations are shown in Table V.
Cell suspensions prepared by mechanical
or enzymic disintegration of tissues are
widely variable in their content of cells
which are dead by morphological criteria,
and it wasnotedthatformation of " stars "
was restricted almost exclusively to dead
cells. Table V indicates for each suspen-
sion examined, whether significant num-
bers of dead cells or of " star " cells were
seen; the percentage of dead cells present-
ing as " star " cells was determined for
half the preparations. The Table shows
that absence of " star " cells was some-
times associated with a scarcity of dead
cells; on the other hand, suspensions
containing numerous dead cells were
quite variable in their content of " star "
cells. In general, lymphoid tissues yield-
ed few or no " star" cells, whereas
solid sarcomata or carcinomata often
yielded many. Cells ofthe ascites tumour
could not be converted to " star " cells
by killing them by heat, or with dilute
alcohol from which the cells were washed
free before testing.
Our observation that cell death almost
invariably precedes the exhibition of
pericellular thromboplasia suggests that
admixed cells which are able to promote
the initiation of tumours from small
inocula of viable cells may actually
require preliminary lethal irradiation as a
condition for expression of their throm-
boplastic activity.
7. Failure of ancrod to inhibit the effect of
LI cells
If the enhancement of tumour takes
by admixed LI cells is associated with a
thromboplastic effect of the latter, their
influence should be reduced or abolished
using recipients having a defect of blood
coagulation which precluded fibrin forma-
tion.
A mixture of 200 V and 225,000 LI
cells of CBA " N.T." was injected sub-
cutaneously in 4 sites in each of 10 CBA
mice in which a severe blood coagulation
TABLE V.-Thromboplastic Activity of Individual Cells in Suspensions Prepared from
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* The only two
" star
" cells seen in the marrow preparation were both megakaryocytes.L. J.. PETERS ANI) H. B. HEWITT
defect ha(l been in(luced by repeated
injections of ancrod according to the
schedule of treatment described in the
previous section. Ten control mice re-
ceived the same inocula of tumour cells
but were given injections of saline at the
same times as the test mice received
ancrod. Although the blood ofthe ancrod
treated mice was shown to be incoagulable
from some hours before until 4 days after
injection of tumour cells, the final inci-
dences of tumours and the mean latent
periods before their appearance (16-5 days)
were not significantly different between
the two groups: 40/40 sites developed
tumours in the treated group, and 38/40
in the control group.
The results of this experiment do
not support the hypothesis it was des-
igned to test. On the other hand, it is
conceivable that blood incoagulability
was not maintained for a sufficiently long
period. Further consideration of this
experiment appears in the Discussion.
DISCUSSION
An association between the growth
or metastasizing potential of tumours and
the formation of fibrin has been the
subject of many publications during the
last two decades. O'Meara (1958) sug-
gested that growth of a tumour is condi-
tional upon the prior formation of a
fibrin lattice in the adjacent tumour bed
and that this formation is maintained by
the tumour itself. Many investigators
have studied the effect of perturbations
ofthe blood coagulation system ofanimals
on the metastasizing potential of tumour
cells embolized from tumours or injected
intravenously. It is not our purpose to
review the extensive reports on this
topic, which are by no means unanimous
in respect of their findings and interpre-
tations. However, it may be said that the
balance of evidence favours the view that
tumour growth or the seeding of embol-
ized cells is enhanced by conditions
which encourage the formation or stability
of fibrin and is decreased by treatments
which inhibit coagulationi or encourage
fibrinolysis (e.g. Ketcham et al., 1971;
Cliffton and Agostino, 1964).
Consideration of the above suggested
to us that the promotion of tumour take
incidence by admixed LI tumour cells
might be associated with a thrombo-
plastic effect of such cells. Strong evi-
dence in favour of this interpretation
was provided by our demonstration that
brain extract, a rich source of thrombo-
plastin, simulated the effect of LI cells
in all of the 3 tumour systems examined.
The similar but less powerful effect of
admixed erythrocytes, first demonstrated
by Yatvin et al. (1973), provided further
supportive evidence, in that Quick et al.
(1954) have shown that erythrocyte lysate
is thromboplastic. The fact that incor-
poration of viable cells in pure fibrin
clots before implantation enhanced their
capacity to give rise to tumours is very
cogent evidence that stimulation of local
fibrin deposition may be implicated in the
Revesz effect.
In a previous publication from this
laboratory (Hewitt et al., 1973) evidence
was presented to show that the effect
of admixed LI cells was to increase the
number of injected clonogenic cells con-
tributing to initiation of a tumour. The
result of such increase would be to raise
the take incidence from a given number
of viable cells and to reduce both the
latent period before appearance oftumours
and the time taken for tumours to reach
a specified, or lethal, size. A possible
interpretation is that many of the viable
cells injected without additive are lost
from the site of injection, the effect of the
additive being to retain them there. The
results of our experiments with 125IUdR-
labelled viable cells support this inter-
pretation and serve to confirm the analogy
between brain extract and LI cells.
These experiments do not in themselves
inform us whether viable cells lost from
the injection site die on site or only after
their emigration from it. That they are
destroyed is proved by their failure to
give rise to tumours elsewhere in the
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animal. It is pertinent here to refer to
our experience that TD50 values for
intravenous injection are commonly much
higher than those for subcutaneous injec-
tion; in the case of the CBA Carcinoma
" N.T." studied by us, the respective
values were > 67,000 and about 2000cells;
similar findings for two other tumours
are reported by Boeryd, Lundin and
Norrby (1971). It is clear that cells
which remain in a subcutaneous injection
site have a relatively high chance of
survival and replication and that those
which leave are exposed to a high risk
ofdestruction byunidentifiedmechanisms.
.In assessing the thromboplastic acti-
vity of nucleated normal or malignant
tissue cells, we have been very largely
guided by our microscopic technique for
observing the thromboplastic activity of
individual cells. It is significant that
lymphocytes and bone marrow cells gave
very little evidence of thromboplastic
activity by this test; it was reported
previously that both these cell types
were entirely without effect on the TD50
when mixed with viable cells of CBA
Carcinoma " N.T." (Hewitt et al., 1973).
Our most important observation using
the test was that thromboplastic activity
was almost totally confined to cells
whose morphological appearance indicated
that they were dead, a significant excep-
tion being megakaryocytes seen in the
marrow cell preparation. Moreover, the
dead cells of different cell suspensions
varied widely in their thromboplastic
activity. This distinction between the
thromboplastic exertions of living and
dead cells clearly cannot be made using
tissue extracts tested by macroscopic
techniques. Our observation suggests
that lethal irradiation of added cells may
serve to ensure a sustained release of
thromboplastic material at the site of
injection over the period required. Cell
killing by radiation is distinguished from
most other methods of cell killing in that
the time between exposure to the noxious
influence and cell death varies very
widely among individual cells; thus, an
input of dead cells into the injection site
would be sustained for several days. It
is of interest in this context to note that
large numbers of cells are known to die
within established tumours (see Steel,
1968). It can be conjectured that pro-
gressive growth of a solid tumour, as well
as its initiation, may sometimes be con-
ditional upon influences which these dead
cells exert.
In view of the large measure of
support for our hypothesis, our failure to
demonstrate inhibition of the Revesz
effect by treatment of injected mice with
the defibrinating agent, ancrod, deserves
further consideration. As judged by the
rate of loss of 125IUdR-labelled cells,
ancrod treatment was continued suffi-
ciently long after injection of tumour
cells; however, it is possible that treat-
ment was not started sufficiently long
before injection of tumour cells to deplete
fibrinogen in the interstitial tissue. Alter-
natively, fibrin deposited by the action
of ancrod itself may have persisted long
enough to provide a suitable micro-
environment for tumour initiation. We
propose to undertake further studies with
ancrod.
Our finding that pure fibrin clots and
erythrocytes, both devoid of nuclear ma-
terial, have some capacity to simulate the
effect of LI cells is discouraging to the
theory that LI cells act by providing
essential nutrients not otherwise available
to the injected tumour cells. Evidence
and arguments against a rival theory-
that LI cells act byinducing localimmuno-
suppression-have been presented else-
where (Hewitt etal., 1973).
We have considered the possibility
that the thromboplastic influence we
have consistently found for effective
additives has some equivalence with the
tumour angiogenesis factor described by
Folkman et at. (1971). Whilst the two
factors could conceivably be elaborated
by a single additive, their distinction is
suggested by our observation that brain
extract, a potent simulator of LI tumour
cells, had no angiogenic effect when testedL. J. PETERS AND H. B. HEWITT
by the implantation of millipore chambers
containing it.
Our present understanding of the
mechanism of the Revesz effect can be
summarized as follows: it is suggested
that, in the case of tumours having a
relatively high TD50 by the subcutaneous
route, a large proportion of viable cells
injected alone either die on site or after
their emigration from the site; the
addition of LI cells (and of some other
additives) to the inocula ensures a sus-
tained thromboplastic influence at the
site with the production of a fibrin
lattice which either prevents emigration
of viable cells or secures their survival at
the site. The fibrin lattice may also
provide the conditions required for stromi-
fication of the growing tumour, as sug-
gested by O'Meara (1958). We suggest
that tissue cell additives do not release
an effective levelofthromboplastic activity
unless and until they undergo degenera-
tive changes.
The superiority of some LI tumour
cell suspensions in exerting the Revesz
effect may be attributable to a high con-
tent of thromboplastic agents in tumour
cells; it may also be partly dependent on
the high proportion of cycling cells in
such suspensions, for an attempt at
mitosis is usually required for the expres-
sion of radiation damage by cell death.
The TD50 for viable tumour cells is
commonly much reduced when the mice
used for transplantation assay have re-
ceived sublethal whole-body irradiation
(WBI). An almost unchallenged inter-
pretation of this finding is that WBI
suppresses an effective level of immunity
in the recipients. However, since the
phenomenon is commonly observed using
isogeneic tumour host systems in which
no other evidence of transplantation
immunity can be demonstrated, we have
been encouraged to question whether
suppression of immunity is implicated
in this effect. It is known that sublethal
WBI, in rats at least, stimulates a sub-
stantial increase in the rate of synthesis
of fibrinogen (John and Miller, 1968)
with peaks at 3 hours and 4 days after
exposure (Nadkarni and Samuel, 1973).
Our present investigations are directed
to an examination of possible common
factors linking the mechanisms whereby
locally injected LI cells, and WBI of the
recipients, reduce the TD50 values for
viable cells of solid tumours transplanted
within isogeneic tumour-host systems.
The question arises whether the Revesz
effect, exerted by the mechanism we
have suggested, has implications for the
course or response to therapy of clinical
cancer. We have already referred to a
possible analogy between the conditions
influencing seeding of metastases from
embolized cells and those affecting the
initiation of tumours from small numbers
of transplanted viable tumour cells. A
further consideration is whether the stim-
ulation of growth of surviving cells which
has been demonstrated in irradiated
tumours undergoing regression (van Peper-
zeel, 1972) is partly dependent on a local
release of thromboplastic substances from
non-surviving cells during expression of
their radiation damage. Finally, we sug-
gest a possible relevance of our studies
to the uncommon but well-documented
phenomenon in which clinical recurrences
or metastases coincide geometrically with
an irradiated area. It seems to us that
release of tissue thromboplastins asso-
ciated with radiation damage could under-
lie this phenomenon, in the same way as
such release is invoked to explain the
predisposition of sites of accidental or
surgical trauma to tumour recurrence or
metastasis. This understanding appears
preferable to that provided by the widely
current and unsupported hypothesis that
irradiation suppresses locally a form of
immunity not independently demon-
strable. The interpretation we have sug-
gested allows us to reconcile the apparent
contradiction between experiments which
demonstrate increased tumour " takes "
in acutely irradiated lung (van den
Brenk et al., 1973) and those which have
shown a reduced rate ofgrowth oftumours
transplanted to pre-irradiated sites (Sten-
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strom et al., 1955; Hewitt and Blake,
1968).
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